ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 (2020)
- Authors:
- USP affiliated authors: PERON, JEAN PIERRE SCHATZMANN - ICB ; NAKAYA, HELDER TAKASHI IMOTO - FCF ; OLIVEIRA, ANTONIO EDSON ROCHA - FCF ; SINGH, YOUVIKA - FCF ; GONÇALVES, ANDRÉ NICOLAU AQUIME - FCF
- Unidades: ICB; FCF
- DOI: 10.1093/infdis/jiaa332
- Subjects: ANGIOTENSINAS; COVID-19; COMORBIDADE; GENES; IMUNOLOGIA; INFECÇÕES RESPIRATÓRIAS; PNEUMOPATIAS; DOENÇAS CARDIOVASCULARES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Infectious Diseases
- ISSN: 1537-6613
- Volume/Número/Paginação/Ano: v. 222, p. 556-563, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PINTO, Bruna G. G et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, v. 222, p. 556-563, 2020Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiaa332. Acesso em: 27 dez. 2025. -
APA
Pinto, B. G. G., Oliveira, A. E. R., Singh, Y., Gonçalves, A. N. A., Ogava, R. L. T., Creighton, R., et al. (2020). ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, 222, 556-563. doi:10.1093/infdis/jiaa332 -
NLM
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1093/infdis/jiaa332 -
Vancouver
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1093/infdis/jiaa332 - An experimental DUAL model of advanced liver damage
- COVID-19 pandemic and dysbiosis: can the ivermectin hysteria lead to an increase of autoimmune neuroinflammatory diseases?
- Susceptibility of the elderly to sars-cov-2 infection: ace-2 overexpression, shedding, and antibody-dependent enhancement (ade)
- Neuroinflammation at single cell level: what is new?
- Immature neutrophil signature associated with the sexual dimorphism of systemic juvenile idiopathic arthritis
- O fenômeno da tolerância oral e a regulação de células patogênicas Th17 no modelo de encefalomielite experimental auto-imune
- Silencing of nuclear factor kappa b 1 gene expression inhibits colony formation, cell migration and invasion via the downregulation of interleukin 1 beta and matrix metallopeptidase 9 in renal cell carcinoma
- Imunomodulação e neuroimunologia em modelos experimentais: encefalomielite autoimune e sindrome congênita do zika vírus
- Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury
- Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19
Informações sobre o DOI: 10.1093/infdis/jiaa332 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
